Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001178913-22-001582
Filing Date
2022-04-25
Accepted
2022-04-25 16:19:18
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 zk2227669.htm 424B5 191644
2 image0.jpg GRAPHIC 79606
3 image1.jpg GRAPHIC 112509
4 image2.jpg GRAPHIC 71833
5 image3.jpg GRAPHIC 107027
  Complete submission text file 0001178913-22-001582.txt   704041
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255658 | Film No.: 22849923
SIC: 2834 Pharmaceutical Preparations